//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfileReplies









Loading...
Do you prescribe hydralazine? Or, do you πŸ›‘ it as soon as you see it? Hydralazine persists despite TID dosing & risks like... vasculitis πŸ”₯ Are you asking Why-dralazine? βœ…The blog by @dramiliflores.bsky.social @nephroseeker.medsky.social #NephSky www.nephjc.com/news/hydralazine-anca-vasculitis
2mo
This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide i...
www.nephjc.com
Why-dralazine?! Population risk of drug induced vasculitis β€” NephJC
Nephrology Journal Club
Have you heard the news? Dapagliflozin is now $8/month at @costplusdrugs.com Wrote my first script this AM From $1935 to $15 for 90 days at 10 mg per day Inflation is everywhere except #Flozins
1mo
Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/
1mo
Joel Topf
A. I am not convinced how a 3X effect in crude becomes a 1.2x effect after PS weighting black box B. As we say in the summary, there are no good reasons to use hydralazine anyways. So small risk:zero benefit = infinite risk:benefit ratio. #NephJC